President Tooker Adin M exercised 21,903 shares at a strike of $49.10 and sold $2,816,979 worth of shares (21,903 units at $128.61), decreasing direct ownership by 0.00% to 31,721 units (SEC Form 4)
$HIG
Property-Casualty Insurers
Finance
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
HARTFORD INSURANCE GROUP, INC. [ HIG ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/15/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 05/15/2025 | M | 8,308 | A | $53.81 | 40,029.067 | D | |||
| Common Stock | 05/15/2025 | M | 6,864 | A | $43.59 | 46,893.067 | D | |||
| Common Stock | 05/15/2025 | M | 6,731 | A | $48.89 | 53,624.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 3,168 | D | $129.2844(2) | 50,456.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 3,281 | D | $129.2763(3) | 47,175.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 3,563 | D | $128.0175(4) | 43,612.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 3,583 | D | $127.9952(5) | 40,029.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 4,005 | D | $129.2622(6) | 36,024.067 | D | |||
| Common Stock | 05/15/2025 | S(1) | 4,303 | D | $128.0088(7) | 31,721.067 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option | $53.81 | 05/15/2025 | M | 8,308 | (8) | 02/27/2028 | Common Stock | 8,308 | $0.0000 | 16,614 | D | ||||
| Stock Option | $48.89 | 05/15/2025 | M | 6,731 | (9) | 02/28/2027 | Common Stock | 6,731 | $0.0000 | 6,731 | D | ||||
| Stock Option | $43.59 | 05/15/2025 | M | 6,864 | (10) | 03/01/2026 | Common Stock | 6,864 | $0.0000 | 0.0000 | D | ||||
| Stock Option | $49.01 | (11) | 02/26/2029 | Common Stock | 26,687 | 26,687 | D | ||||||||
| Stock Option | $51.87 | (12) | 02/23/2031 | Common Stock | 25,202 | 25,202 | D | ||||||||
| Stock Option | $55.27 | (13) | 02/25/2030 | Common Stock | 24,094 | 24,094 | D | ||||||||
| Stock Option | $69.41 | (14) | 02/23/2032 | Common Stock | 24,155 | 24,155 | D | ||||||||
| Stock Option | $78.28 | (15) | 02/28/2033 | Common Stock | 24,301 | 24,301 | D | ||||||||
| Stock Option | $95.74 | (16) | 02/27/2034 | Common Stock | 16,492 | 16,492 | D | ||||||||
| Stock Option | $116.41 | (17) | 02/25/2035 | Common Stock | 25,488 | 25,488 | D | ||||||||
| Explanation of Responses: |
| 1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 14, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| 2. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.69 - $129.63 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.65 - $129.60 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.61 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.52 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.68 - $129.64 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.67 - $128.65 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
| 9. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
| 10. The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
| 11. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
| 12. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
| 13. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
| 14. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. |
| 15. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
| 16. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |
| 17. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date. |
| Anthony J. Salerno, Jr., Attorney-in-Fact | 05/19/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||